Manejo del cáncer de cabeza y cuello: ¿Radioterapia a quién, cuándo y por qué?

Vinés, Eugenio; G, María José Orellana; M, Catalina Bravo; P, David Jofré

doi:10.4067/s0718-48162017000100013

Cited by 5 publications

(5 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study shows that from the 60 participants, 43 (71.67%) are in advanced staging of the disease (III, IV) and, of these, 29 (48.33%) combined the radiation therapy with the surgery, which is consistent with the literature for this audience, which claims that radiation therapy is considered the standard modality for initial stage cancers and, in more advanced cases, the association of radiation therapy with surgery and/or chemical therapy is indicated 5,22-24 .…”

Section: Discussionsupporting

confidence: 79%

Fadiga em pacientes com câncer de cabeça e pescoço em tratamento radioterápico: estudo prospectivo

Avelar

Nicolussi

Toneti

et al. 2019

Rev. Latino-Am. Enfermagem

View full text Add to dashboard Cite

Objetivo identificar a frequência do sintoma de fadiga e domínios afetados nos pacientes com câncer de cabeça e pescoço em tratamento radioterápico, no início, meio e final do tratamento. Método estudo com delineamento quase experimental de corte longitudinal e prospectivo, envolvendo 60 pacientes com câncer de cabeça e pescoço. Destaca-se que este artigo somente abordará os dados do Grupo Controle. As variáveis dependentes foram coletadas por meio de entrevista, utilizando a Escala de Fadiga de Piper – revisada, cujo instrumento multidimensional avalia os domínios global, comportamental, afetivo e sensorial/psicológico. A análise dos dados baseou-se em frequências absolutas e relativas. Resultados houve predomínio do sexo masculino, faixa etária de 41-60 anos, baixa escolaridade e em uso regular de álcool e cigarro. Todos os domínios da escala de fadiga tiveram seus escores aumentados, apresentando valores medianos de maior magnitude em Tempo 2 e Tempo 3, quando comparados aos valores em Tempo 1, indicando aumento nos níveis de fadiga no decorrer do tratamento radioterápico. Conclusão o sintoma de fadiga aumentou no decorrer do tratamento radioterápico, tendo todos os domínios afetados, com isso, ressalta-se a importância da avaliação ao longo do tratamento, por se tratar de um sintoma frequente e debilitante aos pacientes oncológicos.

show abstract

Section: Discussionsupporting

confidence: 79%

Fadiga em pacientes com câncer de cabeça e pescoço em tratamento radioterápico: estudo prospectivo

Avelar

Nicolussi

Toneti

et al. 2019

Rev. Latino-Am. Enfermagem

View full text Add to dashboard Cite

show abstract

“…The treatment contemplates different alternatives, with the main surgery and radiotherapy associated or not with chemotherapy and/or biological therapies, depending on the tumor stage and the functional reserve of the patient [5].…”

Section: Introductionmentioning

confidence: 99%

Intensity Modulated Radiotherapy (IMRT) in the Planning of Hypofractionated Treatment in Head and Neck Tumors

Morales¹,

Moreno²

2018

IJCM

View full text Add to dashboard Cite

Head and neck cancer (HNCC) is the sixth most common cancer with an incidence of approximately 600,000 cases per year and 300,000 annual deaths worldwide 1y2. In Cuba, cancer of the larynx is the fourth cause in incidence, being the fourth cause of cancer death in men. Radiotherapy constitutes an important modality in the control of these tumors and the Intensity Modulated Radiotherapy (IMRT) is a new advance in this field. With it, it is possible to improve dose distribution, decreasing the dose in adjacent healthy tissues and escalating dose in tumor. In this work we present 33 patients of National Institute of Oncology and Radiobiology in Cuba (INOR), in whom the IMRT was used as a treatment technique with a hypofractionation of the dose. Their response was observed at the end of the treatment and one month later. 56% (19) of the patients had a complete response to treatment at the primary site of the tumor and neck. 10% (3) had no response, progressed. 11 of the patients had no response at the lymph node site at the end of treatment, 8 of these 11 had complete remission one month after radiotherapy ended.

show abstract

“…The treatment of these tumors contemplates different alternatives, the main ones being surgery and radiotherapy associated or not with chemotherapy and/or biological therapies, depending on the tumor stage and the functional reserve of the patient [7]. Radiotherapy has a very well established role either in the exclusive treatment or as adjuvant treatment.…”

Section: Introductionmentioning

confidence: 99%

PET/CT and Hypo-Fractionated Radiotherapy of Patients with Head and Neck Cancer

Morales¹,

Ramírez²,

Glez³

et al. 2018

IJCM

View full text Add to dashboard Cite

Positron emission tomography/Computer tomography (PET/CT) is a multimodality imaging diagnostic technique that analyzes the uptake and retention of different radiopharmaceuticals by cells providing metabolic information on biochemical processes. PET/CT has been used for radiotherapy planning, providing useful information to the Radio-oncologist about the localization, size and metabolic activity of tumor lesions. In this paper, we show advantages of the 18F-FDG PET/CT respect to simple CT imaging for target volume delineation in patients with diagnosis of Squamous Head and Neck Carcinoma that has been scheduled to undergo a hypofractionated radiotherapy treatment. On ten studied patients, the target volume defined from PET/CT images was less extensive than those defined from simple CT images. In six patients the target volume was significantly less extensive and in two of them a new lymph node disease was reported, re-staging and corresponding target volume was also delineated with less extensive margins from PET/CT images. A greater accuracy in delineating the volumes and improving the distribution of doses in the planning of the radiant treatment in these patients was possible, allowing a high precision in the delivery of the prescribed dose to the target volume diminishing the maximum dose to the adjacent healthy tissues. In conclusion we show that the use of 18F-FDG PET/CT was superior than the simple CT as the primary modality of imaging for hypofractioned radiotherapy treatment planning in patients with Squamous Head and Neck Carcinoma.

show abstract

Manejo del cáncer de cabeza y cuello: ¿Radioterapia a quién, cuándo y por qué?

Abstract: RESUMENRevisión del enfrentamiento del paciente con cáncer escamoso de la vía aerodigestiva superior, orientada a la radioterapia.Las principales alternativas de tratamiento para los pacientes con cáncer escamoso de cabeza y cuello son la cirugía y la radioterapia (RT)

Cited by 5 publications

References 23 publications

Fadiga em pacientes com câncer de cabeça e pescoço em tratamento radioterápico: estudo prospectivo

Fadiga em pacientes com câncer de cabeça e pescoço em tratamento radioterápico: estudo prospectivo

Intensity Modulated Radiotherapy (IMRT) in the Planning of Hypofractionated Treatment in Head and Neck Tumors

PET/CT and Hypo-Fractionated Radiotherapy of Patients with Head and Neck Cancer

Contact Info

Product

Resources

About